ABSTRACT The risk of early recurrence of pulmonary embolism in patients with venous thromboembolic disease treated by anticoagulants is not well established. To determine the risk linked to contemporary proximal deep venous thrombosis, a prospective study was organised to give clinical and scintigraphic surveillance to 50 patients with angiographically proved pulmonary embolism plus phlebographically proved proximal deep vein thrombosis during the first 15 days of anticoagulant treatment. Perfusion lung scans were performed initially and on days 3, 7, and 15. Only two patients had a recurrence of pulmonary embolism during this period; both episodes were revealed by new symptoms, and one recurrence was fatal. The systematic performance of angiography in four patients found to have new scintigraphic defects led to the the diagnosis of "spurious scintigraphic recurrence" in three of them. It is concluded that (a) adjusted anticoagulant treatment showed an effectiveness of 96% for preventing early recurrence of pulmonary embolism in this group of supposed high risk patients, and (b) in patients with recent pulmonary embolism new defects on systematic perfusion lung scans are not specific indicators of recurrent pulmonary embolism.
The risk of early recurrence of pulmonary embolism during anticoagulant treatment is not well established: the frequency given in published studies varies from zero to 28% during the initial course of intravenous heparin-that is, usually, during first seven to 15 days of treatment.'1-This variation probably has several explanations, some of which, such as the method of heparin administration and the "adequacy" of anticoagulation, have been investigated in prospective comparative studies.2'49 10 Other important factors possibly contributing to these variable results are: (1) only two of these studies9 1 included systematic reassessment by perfusion lung scanning, and these two studies reported the highest recurrence rates (28% and 23%). (2) In all the reported studies the diagnosis of recurring pulmonary embolism was based on clinical or scintigraphic evi-dence, or both, and hence was not definitively established. None used pulmonary angiography as the sole diagnostic endpoint for both pulmonary embolism and subsequent recurrences. (3) Pulmonary angiography was performed in eight patients with suspected submassive pulmonary embolism by injecting the contrast medium "with the stream" in an arm vein; this technique confirmed severe pulmonary vascular obstruction in all eight cases and, in these selected patients, appeared reliable. In all the other patients the injection was made in the pulmonary artery, either in the trunk ("global" opacification) or in the right and left pulmonary arteries successively ("selective" opacification). Only conventional angiography was used. In 45 of the 50 patients catheterisation was performed by percutaneous puncture of a basilic vein and femoral vein catheterisation was used in the others. The scoring system described by Miller et alt4 was used to evaluate the degree of angiographic vascular obstruction; this gives a score ranging from 0 to 34, with a maximum of 16 for intraluminal filling defects and 18 for alterations of peripheral perfusion. In the event of repeat angiography performed because of a suspected recurrence of embolism, the same techniques were used as in the first procedure so that data would be comparable.
The diagnosis of pulmonary embolism depends on the visualisation of one or more intraluminal filling defects or sharp arterial cutoffs in large pulmonary arteries. The diagnosis of recurrent pulmonary embolism required (1) the appearance of one or more intraluminal filling defects or sharp arterial cutoffs in an area not previously affected by the embolic process, or (2) more proximal extension of vascular obstruction than appeared in the reference angiogram. The disappearance of a proximal clot with embolisation of more distal arteries in the same area, without any other changes, was interpreted as fragmentation of the initial clot, and was not considered a recurrence. Perfusion lung scanning Microspheres labelled with technetium-99m albumin were injected intravenously with the patient in the supine position. At least four views were obtained (anterior, posterior, and left and right lateral). Successive perfusion lung scans were compared only with the immediately preceding one and noted as "better perfusion," "no change," "new defect or defects," or "normal." One or more new defects suggested recurrence of pulmonary embolism, and therefore led to repeat pulmonary angiography. Interpretation All phlebographic, angiographic, and scintigraphic evidence was interpreted by several trained chest physicians and radiologists at the time of performance. During the reviewing period at the end of the study all these documents were interpreted again by two independent pairs of chest physician and radiologist, without knowledge of clinical history or of the relationships between pulmonary angiograms and perfusion lung scans. Only minor differences were found between these two interpretations and between the pairs, and there was no diagnostic change in particular with respect to the diagnosis of recurrent embolism. The systematic perfusion scanning revealed new segmental perfusion defects in three patients without any new clinical symptoms (day 7 in one case, day 15 in the other two). In all three patients chest radiographs were normal or unchanged. Subsequent angiography (interval under 24 hours) did not confirm the suspected recurrence, leading to the diagnosis of "spurious scintigraphic recurrence." An example is given in the figure. The total of four patients with new scintigraphic defects includes these three patients, and one patient with "true" recurrent pulmonary embolism detailed in table 3. 
PROTOCOL
In three other patients with new clinical symptoms (pleuritic chest pain or haemoptysis or both) repeat lung scans did not show new defects and this was taken to exclude the diagnosis of appreciable recurrence of pulmonary embolism.
Severe complications of heparin treatment occurred in three patients, resulting in the interruption of treatment and the performance of an inferior vena caval interruption procedure. The complications comprised compressive hematomas related to vascular puncture sites in two patients (on day 5 in both cases), and in one patient heparin induced severe thrombocytopenia on day 9 without any clinically detected embolic or haemorrhagic complication.
Discussion
The risk of pulmonary embolism is especially high in patients with proximal venous thrombosis.12 Furthermore, the severity of a recurrence of pulmonary embolism appears to be related both to the size of the recurring embolus and to the residual pulmonary vascular obstruction at the time of recurrence. The first 15 days of treatment correspond to the commonly accepted period for adherence of the thrombus to vein walls'5 and for the maximum rate of improvement of perfusion as shown by sequential perfusion lung scanning"6; this therefore represents a period during which the importance and potential severity of recurrent embolism are greatest. Thus by choosing patients with proximal deep vein thrombosis and relatively severe pulmonary embolism (the mean Miller index of 16-8 indicates a mean pulmonary vascular obstruction of 50%) we were studying a group of patients with a supposedly high risk of a severe early recurrence of pulmonary embolism.
A recurrence of pulmonary embolism within the first 15 days of treatment was documented in only two of the 50 patients (4%), including one patient whose coagulation test results were inadequate and who died. In the other patient repeat phlebography at the time of recurrence showed proximal extension of the femoral clot despite biologically "adequate" anticoagulation. This latter finding supports the conclusions of Pollak et al, ' who suggested that proximal extension of venous clots during anticoagulant treatment was associated with an increased risk of pulmonary embolism. Since repeat phlebography was not performed systematically, however, we could not compare the early evolution of venous clots in patients without a recurrence of pulmonary embolism.
Early caval interruption is sometimes performed routinely in patients with pulmonary embolism plus proximal deep vein thrombosis.'8 19 Our study provides data that might allow the initiation of a prospective randomised comparison of anticoagulation with and without systematic complementary caval interruption. Because of the low incidence of recurrent pulmonary embolism found in the present work, however, such a study would require a very large number of patients: to demonstrate a significant reduction in recurrence rate-for example, from 5% in the control group treated only by anticoagulation to 1% in the group with an additional procedureobservations of at least 716 proved cases of acute pulmonary embolism would be necessary. 20 Systemic performance of pulmonary angiography in four patients with new scintigraphic defects led to the diagnosis of "spurious scintigraphic recurrence" in three of them ( figure 2 ). This phenomenon, whose frequency is unknown, was first described by Moser et al,2' who attributed it to reperfusion asynchrony between different embolised areas. We must emphasise that our three spurious recurrences, like those described by Moser et al, occurred in very particular conditions: all three patients initially had several embolised areas, the new defects were only segmental, and they occurred in areas where more proximal clots had been seen on the initial angiograms. A retrospective comparison of initial perfusion king scans with initial angiograms confirmed that areas with normal or subnormal perfusion on scans and nonocclusive thrombi on angiograms could be found in virtually all patients with multiple emboli and a Miller index of over 15. Others have made similar comments on such discrepancies between perfusion lung scans and angiograms.22 Thus the present results suggest that, even in patients with recent pulmonary embolism, the specificity of one or more new defects on the perfusion lung scan is insufficient for diagnosing recurrence of pulmonary embolism, especially in the presence of improvement in another area or areas, and indicate that pulmonary angiography should be repeated in such cases to confirm the diagnosis of a recurrence of pulmonary embolism. These results might also help to explain the rather high recurrence rates found in the two studies9" that used systematic surveillance by perfusion lung scanning without confirmation of new defects by repeated pulmonary angiography. Finally, we would emphasise that in this study both patients with a true recurrence of pulmonary embolism had very suggestive symptoms, compared with none in the three patients with "spurious recurrences." Thus systematic perfusion lung scanning appears questionable.
Ventilation scanning was not systematically performed in this study. Its usefulness is, however, established only for the initial diagnosis of pulmonary embolism, and it seems improbable that it would have helped to detect "spurious recurrences" because the Girard, Maathieu, Simonneau, Petitpretz, Cerrina, Herve, Rosso, Musset, Mensch, Duroux abnormalities giving rise to these appear to be purely vascular. In one patient with "spurious recurrence" in whom a simultaneous ventilation scan was obtained, the "new" perfusion defect was, as expected, "mismatched."
This prospective study, although descriptive and non-comparative, allows two main conclusions. Firstly, adjusted anticoagulant treatment showed an effectiveness of 96% for preventing early recurrence of pulmonary embolism in our group of patients with pulmonary embolism plus proximal deep vein thrombosis. Secondly, the specificity of perfusion lung scanning for diagnosing early recurrence of pulmonary embolism in such patients is probably insufficient.
